In addition, SphK1 enzymatic activity and expression are markedly increased in tumor samples from prostate cancer patients (as compared with normal counterparts) correlating with other markers such as PSA level, tumor grade as well as with the clinical outcome after prostatectomy (Malavaud and Cuvillier, submitted). This evidence concerns the gene SPHK1 and neoplasm.